发明名称 PYRIMIDINYLISOXAZOL DERIVATIVE
摘要 <p>An isoxazol derivative, or its pharmacologically acceptable salt, having an excellent P38MAP kinase inhibiting potency, the pyrimidinylisoxazol derivative represented by the formula: wherein R&lt;SUP&gt;1&lt;/SUP&gt; is a hydrogen atom, lower alkyl, amino, halogen atom, lower alkoxy, etc.; R&lt;SUP&gt;2&lt;/SUP&gt; is a substituted or unsubstituted aryl, etc.; R&lt;SUP&gt;3&lt;/SUP&gt; is a hydrogen atom or lower alkyl; R&lt;SUP&gt;4&lt;/SUP&gt; is a substituted or unsubstituted phenyl, etc.; and Y is -CH&lt;SUB&gt;2&lt;/SUB&gt;-, -CO-, -CH(CH&lt;SUB&gt;3&lt;/SUB&gt;)-, -O-, -NH-, etc.</p>
申请公布号 WO2006070927(A1) 申请公布日期 2006.07.06
申请号 WO2005JP24244 申请日期 2005.12.27
申请人 ASKA PHARMACEUTICAL CO., LTD.;HASUMI, KOICHI;OHTA, SHUJI;SAITO, TAKAHISA;SATO, SHUICHIRO;KATO, JUN-YA;SATO, JUN;SUZUKI, HIROYUKI;ASANO, HAJIME;OKADA, MAMI;MATSUMOTO, YASUHIRO;SHIROTA, KAZUHIKO 发明人 HASUMI, KOICHI;OHTA, SHUJI;SAITO, TAKAHISA;SATO, SHUICHIRO;KATO, JUN-YA;SATO, JUN;SUZUKI, HIROYUKI;ASANO, HAJIME;OKADA, MAMI;MATSUMOTO, YASUHIRO;SHIROTA, KAZUHIKO
分类号 A61P1/16;C07D413/04;A61K31/506;A61P1/00;A61P1/04;A61P9/10;A61P3/10;A61P9/00;A61P9/08;A61P9/12;A61P11/00;A61P11/06;A61P13/12;A61P15/00;A61P17/00;A61P17/06;A61P19/00;A61P19/02;A61P19/04;A61P19/06;A61P19/10;A61P25/00;A61P25/28;A61P27/00;A61P29/00;A61P31/04;A61P31/18;A61P35/00;A61P35/04;A61P37/02;A61P37/08;A61P43/00;C07D413/14 主分类号 A61P1/16
代理机构 代理人
主权项
地址